Richard A.F. DIXON,Lei ZHOU,Peter VANDERSLICE,Ke-He RUAN,Zhiqiang CHEN
申请号：
US15305719
公开号：
US20170042985A1
申请日:
2015.04.22
申请国别(地区):
US
年份:
2017
代理人:
摘要：
An effective amount of a composition comprising (i) a plasmid having a cyclooxygenase-prostacyclin synthase fusion gene, and (ii) a carrier fluid for use in treating an individual having a vascular disease or at risk of developing a vascular disease. A composition comprising a carrier fluid； and a DNA sequence encoding for a triple catalytic enzyme, a cDNA sequence encoding for a triple catalytic enzyme, a plasmid comprising a DNA sequence encoding for a triple catalytic enzyme, a fusion gene encoding for a triple catalytic enzyme, a cyclooxygenase-prostacyclin synthase fusion gene, or combinations thereof, for use in treating an individual having a vascular disease or at risk of developing a vascular disease.
